US 12338242
TYK2 inhibitors and uses thereof
granted A61PA61P25/00A61P29/00
Quick answer
US patent 12338242 (TYK2 inhibitors and uses thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P25/00, A61P29/00, A61P35/00, A61P37/00